Bellwethers and notable executives.
-
Joaquin Duato, CEO. Pharma + MedTech (post-Kenvue spin).
-
Albert Bourla, CEO. COVID vaccine + Seagen oncology.
-
Thomas Schinecker, CEO. Pharma + diagnostics; Genentech.
-
Vas Narasimhan, CEO. Patent-protected innovative medicines.
-
Robert Davis, CEO. Keytruda; oncology leader.
-
Robert Michael, CEO. Humira/immunology, oncology.
-
Pascal Soriot, CEO. Oncology, rare disease.
-
Christopher Boerner, CEO. Oncology, immunology, cardio.
-
David Ricks, CEO. GLP-1s (Mounjaro, Zepbound) propelled to top valuations.
-
Paul Hudson, CEO. Pharma + vaccines + consumer.
-
Emma Walmsley, CEO. UK-based; vaccines, specialty meds.
-
Lars Fruergaard Jørgensen, CEO. Diabetes/obesity (Ozempic, Wegovy).
-
Stéphane Bancel, CEO. mRNA platform pioneer.
-
Leonard Schleifer, CEO. Biologics: Eylea, Dupixent.
-
Reshma Kewalramani, CEO. Cystic fibrosis franchise.
-
Daniel O'Day, CEO. HIV, hepatitis, oncology (Trodelvy).